Answers are grounded in this paper and cite their sources.
Background Persistent inflammation and impaired angiogenesis are major contributors to delayed diabetic wound healing. This study investigated whether a chitooligosaccharide–adipose-derived stem cell exosome composite system (Exo-COS) promotes diabetic wound repair through macrophage-mediated immune–vascular communication. Methods ADSC-derived exosomes (ADSC-Exos) were isolated, characterized, and combined with COS to prepare Exo-COS. Under high-glucose conditions, the effects of Exo-COS on macrophage inflammatory–reparative status and migration were evaluated. Macrophage-conditioned medium (MCM) was subsequently used to assess endothelial migration and tube formation. The therapeutic effects were further evaluated in a diabetic rat wound model by histological, immunohistochemical, and wound-healing analyses. Results Exo-COS reduced macrophage CCR7, IL-6, and iNOS expression while increasing Arg-1 and IL-10 expression and enhancing macrophage migration. Exo-COS-treated macrophage-conditioned medium produced the strongest enhancement of endothelial migration and tube formation. In vivo , Exo-COS decreased CCR7 expression, increased Arg-1 expression and CD31-positive microvessel density, promoted collagen deposition and tissue reconstruction, and accelerated wound closure. Conclusion Exo-COS promotes diabetic wound healing by improving macrophage inflammatory–reparative status and enhancing the proangiogenic activity of the macrophage paracrine environment. These findings support macrophage-mediated immune–vascular coupling as a potential mechanism underlying Exo-COS-mediated diabetic wound repair.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: